Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Download PDF of the Conference Program: Click Here.
Presentations will be available 24 hours after their live presentation time
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
-
+
MTE 04 - Radiotherapy for SCLC (Sign Up Required)
- Type: Meet the Expert
- Track: Radiotherapy
- Presentations: 2
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 311 + 312
-
+
MTE 04.01 - Role of Radiotherapy in Multimodality Treatment for SCLC
07:00 - 07:30 | Presenter: Corinne Faivre-Finn
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 04.02 - General Principles of PCI in the Treatment of SCLC
07:30 - 08:00 | Presenter: David L Ball
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 05 - Neuroendocrine Tumors: Pathology and Genetic Update (Sign Up Required)
- Type: Meet the Expert
- Track: Biology/Pathology
- Presentations: 1
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 313 + 314
-
+
MTE 05.01 - Neuroendocrine Tumors: Pathology and Genetic Update
07:00 - 08:00 | Presenter: Elisabeth Brambilla
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 06 - Lung Cancer Pathology Update (Sign Up Required)
- Type: Meet the Expert
- Track: Biology/Pathology
- Presentations: 1
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 315
-
+
MTE 06.01 - Lung Cancer Pathology Update
07:00 - 08:00 | Presenter: Andre L. Moreira
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 07 - Molecular Biology: Minimum Requirement for Clinicians (Sign Up Required)
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
- Presentations: 2
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 501
-
+
MTE 07.01 - Molecular Biology that Clinicians Should Know: From a Clinical Viewpoint
07:00 - 07:30 | Presenter: Prasad S. Adusumilli
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 07.02 - Molecular Biology that Clinicians Should Know: From a Basic Viewpoint
07:30 - 08:00 | Presenter: Martin Filipits
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 08 - Technical Details of EBUS and EUS (Sign Up Required)
- Type: Meet the Expert
- Track: Pulmonology/Endoscopy
- Presentations: 2
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 502
-
+
MTE 08.01 - Technical Aspects of EBUS-TBNA for Clinicians
07:00 - 07:30 | Presenter: Takahiro Nakajima
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 08.02 - Clinical Aspects of EUS(B)-FNA
07:30 - 08:00 | Presenter: Bin Hwangbo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 09 - Management of Difficult Symptoms (Sign Up Required)
- Type: Meet the Expert
- Track: Nursing/Palliative Care/Ethics
- Presentations: 2
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 503
-
+
MTE 09.01 - Management of Difficult Symptoms
07:00 - 07:30 | Presenter: Richard J Gralla
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 09.02 - Symptom Experiences and Symptom Clusters in Advanced Lung Cancer
07:30 - 08:00 | Presenter: Sanjay Popat
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MTE 10 - Bridging the Gap between Genomics and Clinics (Sign Up Required)
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
- Presentations: 2
- Coordinates: 10/16/2017, 07:00 - 08:00, Room 511 + 512
-
+
MTE 10.01 - Bridging the Gap between Genomics and Clinics
07:00 - 07:30 | Presenter: Christian Rolfo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MTE 10.02 - Bridging the Gap between Genomics and Clinics
07:30 - 08:00 | Presenter: Julien Sage
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL 01 - Prevention, Screening, and Management of Screen-Detected Lung Cancer
- Type: Plenary Session
- Track: Radiology/Staging/Screening
- Presentations: 5
- Moderators:Michael Boyer
- Coordinates: 10/16/2017, 08:15 - 09:45, Plenary Hall (Exhibit Hall D)
-
+
PL 01.01 - Current Status of Smoking Cesession Program (Tobacco Control)
08:15 - 08:35 | Presenter: Carolyn Dresler
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 01.02 - Major Advances in CT Screening: A Radiologist's Perspective
08:35 - 08:55 | Presenter: Claudia I Henschke
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 01.03 - Changing Epidemiology in Lung Cancer
08:55 - 09:15 | Presenter: Mary Reid
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 01.04 - What is the Optimal Management of Screen-Detected Lung Cancers
09:15 - 09:35 | Presenter: Shun-ichi Watanabe
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PL 01.05 - Q&A
09:35 - 09:45
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Advanced NSCLC
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- Presentations: 80
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.01-001 - Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial
09:30 - 09:30 | Presenter: D. Ross Camidge
- Abstract
Loading... -
+
P1.01-002 - TP53 Mutations Predict for Poor Survival in ALK Rearrangement Lung Adenocarcinoma Patients Treated with Crizotinib
09:30 - 09:30 | Author(s): W. Wang
- Abstract
Loading... -
+
P1.01-003 - Patients Harboring a Novel PIK3CA Point Mutation after Acquired Resistance to Crizotinib in ROS1 Rearrangement Adenocarcinoma: A Case Report
09:30 - 09:30 | Author(s): M. Fang
- Abstract
Loading... -
+
P1.01-004 - Hypertension With Brigatinib: Experience in ALTA, a Randomized Phase 2 Trial in Crizotinib-Refractory ALK+ NSCLC
09:30 - 09:30 | Presenter: D. Ross Camidge
- Abstract
Loading... -
+
P1.01-005 - Overall Survival (OS) After Disease Progression (PD) on Brigatinib in Patients With Crizotinib-Refractory ALK+ NSCLC in ALTA
09:30 - 09:30 | Presenter: Corey J Langer
- Abstract
Loading... -
+
P1.01-006 - Effect of EML-Alk Fusion Variant and Fusion Abundance on the Efficacy of Crizotinib in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tang Feng Lv
- Abstract
Loading... -
+
P1.01-007 - ALK Testing Trends and Patterns Among Community Practices in the United States
09:30 - 09:30 | Presenter: Peter B Illei
- Abstract
Loading... -
+
P1.01-008 - Real-World Patient Characteristics, Testing and Treatment Patterns of ALK+ NSCLC
09:30 - 09:30 | Presenter: Matthew A Gubens
- Abstract
Loading... -
+
P1.01-009 - Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Jin Kang
- Abstract
Loading... -
+
P1.01-010 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC
09:30 - 09:30 | Presenter: Yangsi Li
- Abstract
Loading... -
+
P1.01-011 - Pattern of Care and Survival of ALK Rearranged Non-Small Cell Lung Cancer in Two Australian Referral Centres
09:30 - 09:30 | Presenter: Malinda Itchins
- Abstract
Loading... -
+
P1.01-012 - Ceritinib in Anaplastic Lymphoma Kinase (ALK)+ NSCLC Patients Pretreated With Only Crizotinib: ASCEND-1 Subgroup Analysis
09:30 - 09:30 | Presenter: Alice Shaw
- Abstract
Loading... -
+
P1.01-013 - Patient-Reported Outcomes and Safety from the Phase III ALUR Study of Alectinib vs Chemotherapy in Pre-Treated ALK+ NSCLC
09:30 - 09:30 | Presenter: Julien Mazieres
- Abstract
Loading... -
+
P1.01-014 - Feasibility of Liquid Biopsy Using Plasma and Platelets for Detection of ALK Rearrangements in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Cheol-Kyu Park
- Abstract
Loading... -
+
P1.01-015 - Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Final Results of the METROS Trial
09:30 - 09:30 | Presenter: Lorenza Landi
- Abstract
Loading... -
+
P1.01-016 - Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib
09:30 - 09:30 | Presenter: Ben J Solomon
- Abstract
Loading... -
+
P1.01-017 - ALK-Rearranged May Promote VTE by Increasing the Expression of TF in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Author(s): Y. Sen
- Abstract
Loading... -
+
P1.01-018 - Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression
09:30 - 09:30 | Presenter: Anna Li
- Abstract
Loading... -
+
P1.01-019 - ALK+ Non-Small Cell Lung Cancer Treated with First Line Crizotinib: Patient Characteristics, Treatment Patterns, and Survival
09:30 - 09:30 | Presenter: Claudio Martín
- Abstract
Loading... -
+
P1.01-020 - Translocation ALK/EML4+ in Non-Squamous NSCLC Population and Crizotinib: What Can We Tell?
09:30 - 09:30 | Author(s): N.C. Pereira
- Abstract
Loading... -
+
P1.01-021 - FISH and IHC Discordance in ALK Rearranged Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Akhil Kapoor
- Abstract
Loading... -
+
P1.01-022 - Prediction of Central Nervous System Progression During Crizotinib Treatment in ALK+ NSCLC Among Hispanics
09:30 - 09:30 | Author(s): A. Ruiz Patino
- Abstract
Loading... -
+
P1.01-023 - ALK-Positive NSCLC: A TMH Experience
09:30 - 09:30 | Author(s): V. Noronha
- Abstract
Loading... -
+
P1.01-024 - Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India
09:30 - 09:30 | Presenter: Anuradha Choughule
- Abstract
Loading... -
+
P1.01-025 - Biomarker Testing in Advanced NSCLC: A Simulation-Based Assessment of Medical Oncologists
09:30 - 09:30 | Presenter: Tara Herrmann
- Abstract
Loading... -
+
P1.01-026 - Circulating miR-206 in Advanced Stage Lung Cancer Patients and Its Association with Cancer Cachexia
09:30 - 09:30 | Presenter: Noorwati Sutandyo
- Abstract
Loading... -
+
P1.01-027 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse
09:30 - 09:30 | Presenter: Si-Yang Liu
- Abstract
Loading... -
+
P1.01-028 - Characteristics of Cell Free DNA in Lung Cancer Patients
09:30 - 09:30 | Presenter: Tomonori Abe
- Abstract
Loading... -
+
P1.01-029 - Lymphocyte Monocyte Ratio as a Prognostic Factor in Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tarkan Yetisyigit
- Abstract
Loading... -
+
P1.01-030 - Predictive Biomarkers in Non-SmallCell Carcinoma and Their Clinical Association
09:30 - 09:30 | Presenter: Anurag Mehta
- Abstract
Loading... -
+
P1.01-031 - Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
09:30 - 09:30 | Presenter: Lisa Wang
- Abstract
Loading... -
+
P1.01-032 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART)
09:30 - 09:30 | Presenter: Tony SK Mok
- Abstract
Loading... -
+
P1.01-033 - Thrombogenic Biomarkers in Patients with NSCLC – Associations with Thrombosis, Progression, and Survival
09:30 - 09:30 | Presenter: Marliese Alexander
- Abstract
Loading... -
+
P1.01-034 - Cerebrospinal Fluid and Plasma Tumor DNA Profiling Reveals Heterogeneity of CNS Metastasis in Patients with Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Wang
- Abstract
Loading... -
+
P1.01-035 - A Next Generation Sequencing and Characteristics Based Model for Predict Clinical Benefit of Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Yongchang Zhang
- Abstract
Loading... -
+
P1.01-036 - Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer
09:30 - 09:30 | Presenter: Jennifer C King
- Abstract
Loading... -
+
P1.01-037 - Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival
09:30 - 09:30 | Presenter: Shun Lu
- Abstract
Loading... -
+
P1.01-038 - Identification and Characterization of Circulating Tumor Cells from Lung Cancer Patients for Selecting Target Anticancer Drugs for Relapse
09:30 - 09:30 | Presenter: Bong-Seog Kim
- Abstract
Loading... -
+
P1.01-039 - Survival Impact of Next-Generation Sequencing in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva
- Abstract
Loading... -
+
P1.01-040 - Clinical Utility of Plasma-Based NGS for Advanced-Stage NSCLC Patients with Insufficient or Unavailable Tumor Tissue
09:30 - 09:30 | Author(s): J. Zugazagoitia
- Abstract
Loading... -
+
P1.01-041 - Role of Re-Biopsy During Disease Progression Non-Small Cell Lung Cancer for Acquired Resistance Analysis and Directing Oncology Treatments
09:30 - 09:30 | Presenter: Masatoshi Kakihana
- Abstract
Loading... -
+
P1.01-042 - Dynamic ctDNA Assay by Next Generation Sequencing to Guide Targeted Therapy in Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): D. Liu
- Abstract
Loading... -
+
P1.01-043 - Molecular Testing for Non-Small Cell Lung Cancer in Latin American
09:30 - 09:30 | Author(s): J. Cé Coelho
- Abstract
Loading... -
+
P1.01-044 - Detection of Circulating Tumor Cells Is Associated with Disease Burden in Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): O. Fiste
- Abstract
Loading... -
+
P1.01-045 - Companion Diagnostic Tests for EGFR, ALK and ROS-1 vs NGS in Advanced NSCLC Patients - Which Is the Best in Terms of Cost and Effective?
09:30 - 09:30 | Presenter: Luciene Schluckebier
- Abstract
Loading... -
+
P1.01-046 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study
09:30 - 09:30 | Presenter: Lucheng Zhu
- Abstract
Loading... -
+
P1.01-047 - Analysis of EGFR Mutation Status in CSF and Blood in Lung Adenocarcinoma Patients with EGFR Mutation and CNS Metastasis
09:30 - 09:30 | Author(s): Y. Sen
- Abstract
Loading... -
+
P1.01-048 - Clinical Impact of EGFR Mutation on Brain Metastasis in NSCLC Patients: A Meta-Regression Analysis
09:30 - 09:30 | Presenter: Chien-Chung Lin
- Abstract
Loading... -
+
P1.01-049 - Conformity of EGFR Mutation Status Between Blood Plasma and Tumor Tissue Samples Among NSCLC Adenocarcinoma Patients, at Dr. H. A. Rotinsulu Lung Hospital. A Preliminary Study
09:30 - 09:30 | Presenter: Reza Kurniawan Tanuwihardja
- Abstract
Loading... -
+
P1.01-050 - Cost-Effectiveness of PDL1 Based Test-And-Treat Strategy with Pembrolizumab as the 1st Line Treatment for NSCLC in Hong Kong
09:30 - 09:30 | Presenter: Herbert H Loong
- Abstract
Loading... -
+
P1.01-051 - Nivolumab Versus Chemotherapy as Post-Platinum Therapy for Advanced Non-Small Cell Lung Cancer in a Real-world Setting
09:30 - 09:30 | Author(s): M. Moezi
- Abstract
Loading... -
+
P1.01-052 - Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): Rodolfo Bordoni
- Abstract
Loading... -
+
P1.01-053 - Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain Metastases
09:30 - 09:30 | Presenter: Lucio Crinò
- Abstract
Loading... -
+
P1.01-054 - PD-L1 Expression in Patients with Non-Small Cell Lung Cancer According to Underlying Pulmonary Disease: A Retrospective Study
09:30 - 09:30 | Presenter: Sayaka Ohara
- Abstract
Loading... -
+
P1.01-055 - Spectrum of Early Progression in Advanced NSCLC Patients Treated with PD-1 Inhibitors: Identifying Markers for Poor Outcome
09:30 - 09:30 | Presenter: Mizuki Nishino
- Abstract
Loading... -
+
P1.01-056 - Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis
09:30 - 09:30 | Presenter: Tatiana I Ionova
- Abstract
Loading... -
+
P1.01-057 - Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Author(s): J. Rogado
- Abstract
Loading... -
+
P1.01-058 - Real World Data with Nivolumab: Experience in Argentina
09:30 - 09:30 | Presenter: Claudio Martin
- Abstract
Loading... -
+
P1.01-059 - Combination Pembrolizumab and Low Dose Weekly Carboplatin/Paclitaxel for Patients with Recurrent/Metastatic NSCLC and PS of 2
09:30 - 09:30 | Presenter: Tamjeed Ahmed
- Abstract
Loading... -
+
P1.01-060 - Nivolumab after Progression to Platinum- Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Mariana López Flores
- Abstract
Loading... -
+
P1.01-061 - The Efficacy and Safety of Anti-PD-1 in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Systematic Review
09:30 - 09:30 | Presenter: Mingyi Di
- Abstract
Loading... -
+
P1.01-062 - KRAS Mutations (KRAS-Mut) and antiPD1/PDL1 Therapy in a Cohort of Lung Cancer (LC) Patients (P). Experience from a Single Institution
09:30 - 09:30 | Author(s): T. Morán
- Abstract
Loading... -
+
P1.01-063 - Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
09:30 - 09:30 | Author(s): J. Cé Coelho
- Abstract
Loading... -
+
P1.01-064 - Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kohei Yamane
- Abstract
Loading... -
+
P1.01-065 - Treatment Beyond Progression with Nivolumab in Patients with Advanced Non-Squamous NSCLC: Results from the Italian Expanded Access Program
09:30 - 09:30 | Presenter: Enrico Cortesi
- Abstract
Loading... -
+
P1.01-066 - PDL-1 Expression of Tumor Cell, Macrophage, and Immune Cells on Pleural Effusion
09:30 - 09:30 | Presenter: Yen-Han Tseng
- Abstract
Loading... -
+
P1.01-067 - Characteristics and Survival Rate of Non-Small Cell Lung Cancer in Patients 45 Years of Age or Younger
09:30 - 09:30 | Presenter: Noorwati Sutandyo
- Abstract
Loading... -
+
P1.01-068 - Impact of Case-Based CME on Physician Performance in the Diagnosis and Management of NSCLC
09:30 - 09:30 | Author(s): Tara Herrmann
- Abstract
Loading... -
+
P1.01-069 - Clinical Experience with IBM Watson for Oncology (WFO) Cognitive System for Lung Cancer Treatment in China
09:30 - 09:30 | Author(s): N. Zhou
- Abstract
Loading... -
+
P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study
09:30 - 09:30 | Author(s): J. Lee
- Abstract
Loading... -
+
P1.01-071 - High Dose IVAA Synergy with mEHT in Patients with Stage III-IV NSCLC: A Phase I Study
09:30 - 09:30 | Presenter: Junwen Ou
- Abstract
Loading... -
+
P1.01-072 - Epithelial-To-Mesenchymal Transition (EMT) in Lung Cancer: Classic Reproduction
09:30 - 09:30 | Presenter: Huibin Liu
- Abstract
Loading... -
+
P1.01-073 - Over-Expression of GGPPs Contributes to Tumor Metastasis and Correlates with Poor Prognosis of Lung Adenocarcinoma
09:30 - 09:30 | Author(s): Tang Feng Lv
- Abstract
Loading... -
+
P1.01-074 - Exosomal RNA-Profiling of Lung Pleural Effusions Identifies Adenocarcinoma Patients through Elevated miR-200 Expression
09:30 - 09:30 | Presenter: Per Hydbring
- Abstract
Loading... -
+
P1.01-075 - Simultaneous Multiplex Profiling of Gene Fusions, METe14 Mutations and Immune Genes in Advanced NSCLC by NCounter Technology
09:30 - 09:30 | Presenter: Noemi Reguart
- Abstract
Loading... -
+
P1.01-076 - Comparison of PANA Mutyper and PNA Clamping for Detecting KRAS Mutations in Tumor Tissue, Cell Block and Pleural Effusion from Cancer
09:30 - 09:30 | Presenter: Chan Kwon Park
- Abstract
Loading... -
+
P1.01-077 - Oncogenic Potential of a Novel HER2 755PL In-Frame (HER2PL) Mutation in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Anya Maan-Yuh Lin
- Abstract
Loading... -
+
P1.01-078 - Longitudinal Studies of Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Target Therapy
09:30 - 09:30 | Presenter: Lin Zhi Xuan
- Abstract
Loading... -
+
P1.01-078a - The Construction and Clinical Application of an Integrated Microfluidic Device for CTCs Detection in Patients with NSCLC
09:30 - 09:30 | Author(s): J. Jiang
- Abstract
No abstract available for this presentation
-
+
P1.01-078b - Dose-Paiting Radiation with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Junchao Wang
- Abstract
Loading...
-
+
P1.02 - Biology/Pathology
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
- Presentations: 73
- Coordinates: 10/16/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P1.02-001 - SLFN11 Expression in Early Stage Non-Small Cell Lung Cancer Predicts Benefit from Adjuvant Chemotherapy with Taxane and Platinum
09:30 - 09:30 | Presenter: Vamsidhar Velcheti
- Abstract
Loading... -
+
P1.02-002 - Diagnostic Utility of MUC4 Expression to Differentiate Epithelioid Mesothelioma from Lung Adenocarcinoma and Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Vishwa Jeet Amatya
- Abstract
Loading... -
+
P1.02-003 - Prevention of Adriamycin-induced Cardiac Damage by NAD-ModulationPrevention of Adriamycin-induced Cardiac Damage by NAD-Modulation
09:30 - 09:30 | Presenter: Sei-Hoon Yang
- Abstract
Loading... -
+
P1.02-004 - Long Non-Coding RNA XLOC_000090 Promotes Lung Cancer Migration Through Modulation of miR-4505
09:30 - 09:30 | Presenter: Bin Zhang
- Abstract
Loading... -
+
P1.02-005 - Solving the Interfering Problem of Tissue Embedding OCT Compound in Activity Based Multiplex Profiling of Tyrosine Kinase Substrates
09:30 - 09:30 | Author(s): S. Arni
- Abstract
Loading... -
+
P1.02-006 - Arsenic Promotes Persistent Alterations in the Lung PiRNA Transcriptome to Target Epigenetic Pathways
09:30 - 09:30 | Presenter: Victor D Martinez
- Abstract
Loading... -
+
P1.02-007 - TP53 and DNA-Repair Gene Polymorphisms as Risk Factors for the Development of Advanced Lung Adenocarcinoma in Serbia
09:30 - 09:30 | Presenter: Jelena Spasic
- Abstract
Loading... -
+
P1.02-008 - Expression of Mismatch Repair Proteins Associates with Survival and Response to EGFR Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
09:30 - 09:30 | Presenter: Hsiang-Ling Ho
- Abstract
Loading... -
+
P1.02-009 - Accumulation of Mutations in Background Normal Lung Tissue Constitutes a Major Lung Cancer Risk
09:30 - 09:30 | Presenter: Emi Kubo
- Abstract
Loading... -
+
P1.02-010 - Novel Role of hSSB2 in the Base Excision Repair Pathway (BER)
09:30 - 09:30 | Author(s): A. Naqi
- Abstract
Loading... -
+
P1.02-011 - XRCC6BP1: A Key Player in the DNA Repair of Cisplatin Resistant NSCLC Cells
09:30 - 09:30 | Presenter: Martin P Barr
- Abstract
Loading... -
+
P1.02-012 - Profiling DNA Repair in Lung Cancer
09:30 - 09:30 | Presenter: Alexander Dobrovic
- Abstract
Loading... -
+
P1.02-013 - ATM Mutation as a Predictor for Mutation Burden in NSCLC
09:30 - 09:30 | Author(s): L.F. Petersen
- Abstract
Loading... -
+
P1.02-014 - TGFalpha Promotes Growth of Lung Tumors Carrying EGFR Mutation but not KRAS Mutation in Transgenic Mouse Models in Vivo
09:30 - 09:30 | Presenter: Koichi Tomoshige
- Abstract
Loading... -
+
P1.02-015 - Comparison of Study Models of Lung Cancer
09:30 - 09:30 | Author(s): J. Jang
- Abstract
Loading... -
+
P1.02-016 - Establishment of Lung Adenocarcinoma Organoid Cultures
09:30 - 09:30 | Presenter: Hirotsugu Notsuda
- Abstract
Loading... -
+
P1.02-017 - Freely Floating Cancer Cells in Lymph Node Sinuses of Hilar Lymph Node Positive Lung Cancer Patients
09:30 - 09:30 | Presenter: Yusuke Nakamura
- Abstract
Loading... -
+
P1.02-018 - Number of Cancer Cells in Lung Adenocarcinoma Specimen – Correlation with Noguchi's Classification, WHO Pathologic Type, and Prognosis
09:30 - 09:30 | Presenter: Takashi Inoue
- Abstract
Loading... -
+
P1.02-019 - Dual Role of Notch in Lung Cancer
09:30 - 09:30 | Presenter: Sara Sinicropi-Yao
- Abstract
Loading... -
+
P1.02-020 - Acinar-Predominant Pattern Correlates with Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung
09:30 - 09:30 | Presenter: Gengpeng Lin
- Abstract
Loading... -
+
P1.02-021 - Can 18F-FDG PET/CT Predict the Pathological Necrosis and Microvessel Density in Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Young Wha Koh
- Abstract
Loading... -
+
P1.02-022 - Spontaneous Regression of Primary Pulmonary Synovial Sarcoma; A Case Report
09:30 - 09:30 | Presenter: Naoko Miyata
- Abstract
Loading... -
+
P1.02-023 - TGF-β Signaling Mediated by Fibroblasts is Associated with the Histological Subtypes of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Ryo Sato
- Abstract
Loading... -
+
P1.02-024 - Correlation of Maximal Tumor Diameter between Pathology Specimen and CT in Nonsmall Cell Lung Cancer: A Pilot Study
09:30 - 09:30 | Presenter: Heae Surng Park
- Abstract
Loading... -
+
P1.02-025 - A Case of Primary Peripheral Epithelial–Myoepithelial Carcinoma of the Lung
09:30 - 09:30 | Presenter: Daisuke Eriguchi
- Abstract
Loading... -
+
P1.02-026 - The Characteristics of Lymph Node Metastasis in Resected Adenosquamous Lung Cancer
09:30 - 09:30 | Author(s): J. Shen
- Abstract
Loading... -
+
P1.02-027 - Minute Pulmonary Meningothelial-Like Nodules Presenting as Multiple Ground-Glass Density Nodules (GGNs): A Case Report
09:30 - 09:30 | Presenter: Yeon Bi Han
- Abstract
Loading... -
+
P1.02-028 - Pathways Involved in Early Stage Lung Cancers
09:30 - 09:30 | Presenter: Vilde D Haakensen
- Abstract
Loading... -
+
P1.02-029 - Pulmonary Adenofibroma with Cystic Change: A Case Report
09:30 - 09:30 | Presenter: Eunhyang Park
- Abstract
Loading... -
+
P1.02-030 - The Effect of Chronic Obstructive Pulmonary Disease on the Tumor Stroma in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yasuhiko Ohshio
- Abstract
Loading... -
+
P1.02-031 - Clinicopathological Study of 16 Cases with Pulmonary Pleomorphic Carcinoma
09:30 - 09:30 | Presenter: Fumi Ohsawa
- Abstract
Loading... -
+
P1.02-032 - Clinicopathological Profile of Invasive Mucinous Adenocarcinoma Based on Evaluation of Invasive Components
09:30 - 09:30 | Presenter: Yuichi Mitsui
- Abstract
Loading... -
+
P1.02-033 - Differentiating of Cytomorphological Characteristics in Non-Small Cell Lung Cancer Predicts Value of Radiologic Features
09:30 - 09:30 | Presenter: Ryota Tanaka
- Abstract
Loading... -
+
P1.02-034 - Non-Invasive Qualitative Diagnosis of Lung Cancer Enabled by Spectrum Analysis of Ultrasound
09:30 - 09:30 | Author(s): R. Ihara
- Abstract
Loading... -
+
P1.02-035 - Human Papillomavirus Infection in Lung Squamous Cell Carcinoma and Correlation to p16 INK4a Expression from an Argentine Population
09:30 - 09:30 | Author(s): M.M. García Falcone
- Abstract
Loading... -
+
P1.02-036 - Fine Needle Aspiration as a Diagnostic Tool in Lung Cancer: Worth Pursuing?
09:30 - 09:30 | Author(s): E.T. Cunha
- Abstract
Loading... -
+
P1.02-037 - Pulmonary Carcinoid Tumors: A Prognostic Implications of Ki-67 Proliferative Index
09:30 - 09:30 | Presenter: Renata Langfort
- Abstract
Loading... -
+
P1.02-038 - Bilateral Combined Lymphangioleiomyomatosis and Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia with Typical Carcinoids
09:30 - 09:30 | Presenter: Jan Hinrich Von Der Thüsen
- Abstract
Loading... -
+
P1.02-039 - Preventive and Therapeutic Action of Id1 Inhibition in KRAS-Mutant (KM) Lung Adenocarcinoma (LAC) Tumors in a Xenograft Murine Model
09:30 - 09:30 | Presenter: Marta Roman Moreno
- Abstract
Loading... -
+
P1.02-040 - Genetic Risk Evaluation in Families with Lung Cancer History in High Lung Cancer Mortality Region of Xuanwei, China
09:30 - 09:30 | Presenter: Madiha Kanwal
- Abstract
Loading... -
+
P1.02-041 - Mutation of SWI/SNF Complex Genes Is Frequent in Poorly Differentiated, Mesenchymal-Like Lung Cancer without Major Driver Mutation
09:30 - 09:30 | Presenter: Taichiro Yoshimoto
- Abstract
Loading... -
+
P1.02-042 - Circadian Clock Gene Per2 Over-Expression Inhibits Tumor Progression in Human Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Li Qiang
- Abstract
Loading... -
+
P1.02-043 - A Comparison of Consistency of Detecting BRAF Gene Mutations in Peripheral Blood and Tumor Tissue of Non-Small-Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): M. Fang
- Abstract
Loading... -
+
P1.02-044 - Relationship between RET Rearrangement and Thymidylate Synthase mRNA Expression in Non-Small Cell Lung Cancer Tissues
09:30 - 09:30 | Author(s): Chunwei Xu
- Abstract
Loading... -
+
P1.02-045 - PIK3CA Mutations in Chinese Patients with Non-Small-Cell Lung Cancer
09:30 - 09:30 | Author(s): B. Wu
- Abstract
Loading... -
+
P1.02-046 - Mutational Subtypes and Prognosis of Non-Small-Cell Lung Cancer Harboring HER2 Mutations
09:30 - 09:30 | Author(s): Chunwei Xu
- Abstract
Loading... -
+
P1.02-047 - Mutational Features and Prognosis of Non-Small-Cell Lung Cancer Harboring RAS Mutations
09:30 - 09:30 | Author(s): Y. Zhu
- Abstract
Loading... -
+
P1.02-048 - Somatic Mutation Analysis of RB1 Gene in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): W. Wang
- Abstract
Loading... -
+
P1.02-049 - Detection of CDKN2A Gene Mutations in Patients with Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): S. Wang
- Abstract
Loading... -
+
P1.02-050 - Pan-Can Analysis of miRNAs at the Imprinted Chromosome 14q32 Locus Reveals a Unique Pattern of Deregulation in NSCLC
09:30 - 09:30 | Presenter: Jhon Ralph Enterina
- Abstract
Loading... -
+
P1.02-051 - Ultra-Deep Sequencing Depicts the Genomic Landscape of Ground-Glass Nodules in Early Stage Lung Adenocarcinoma
09:30 - 09:30 | Author(s): Wu Nan
- Abstract
Loading... -
+
P1.02-052 - Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma
09:30 - 09:30 | Presenter: Masatsugu Kuraoka
- Abstract
Loading... -
+
P1.02-053 - A New Strategy of Adjuvant Chemotherapy for Lung Cancer Based on the Expression of Anti-Aging Gene Klotho
09:30 - 09:30 | Presenter: Kyoshiro Takegahara
- Abstract
Loading... -
+
P1.02-054 - The Molecular Characterisation of Lung Adenocarcinoma Subgroups
09:30 - 09:30 | Presenter: Elizabeth Starren
- Abstract
Loading... -
+
P1.02-055 - Genotyping Squamous Cell Lung Carcinoma Among Hispanics (Geno1.1-CLICaP)
09:30 - 09:30 | Presenter: Andrés F. Cardona
- Abstract
Loading... -
+
P1.02-056 - BRAF Non-V600E Mutations Recurrently Found in Non-Small Cell Lung Cancer in Chinese Patients
09:30 - 09:30 | Author(s): Q. Xu
- Abstract
Loading... -
+
P1.02-057 - Analysis of C-MET Amplification Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
09:30 - 09:30 | Author(s): Chunwei Xu
- Abstract
Loading... -
+
P1.02-058 - Molecular Characteristics and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NFE2L2 Mutations
09:30 - 09:30 | Author(s): W. Wang
- Abstract
Loading... -
+
P1.02-059 - Molecular Characteristics of SMARCA4 Mutations Detection in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Author(s): X. Chen
- Abstract
Loading... -
+
P1.02-060 - Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
09:30 - 09:30 | Presenter: Yohei Yurugi
- Abstract
Loading... -
+
P1.02-061 - Podoplanin Expression in Cancer-Associated Fibroblasts Predicts Unfavourable Prognosis in Patients with Stage IA Adenocarcinoma
09:30 - 09:30 | Presenter: Yasuaki Kubouchi
- Abstract
Loading... -
+
P1.02-062 - Ring Finger Protein 38 Promote Non-Small Cell Lung Cancer Progression by Endowing Cell EMT Phenotype
09:30 - 09:30 | Presenter: Jian-Yong Ding
- Abstract
Loading... -
+
P1.02-063 - Tumor Heterogeneity Analyses by Integrated Proteo-Genomics of Thoracic Tumors from Sequential Biopsies and Warm Autopsies
09:30 - 09:30 | Author(s): N. Roper
- Abstract
Loading... -
+
P1.02-064 - Proteomic Analysis of Exosome Purified Using a Novel Reagent
09:30 - 09:30 | Presenter: Ayako Kurimoto
- Abstract
Loading... -
+
P1.02-065 - Histone Deacetylase Inhibition Alters Stem Cell Phenotype in Gefitinib-Resistant Lung Cancer Cells with EGFR Mutation
09:30 - 09:30 | Presenter: Fariz Nurwidya
- Abstract
Loading... -
+
P1.02-066 - Cancer Stem Cells in Pulmonary High Grade Neuroendocrine Carcinoma: a Series of 23 Cases from Eastern India
09:30 - 09:30 | Author(s): S. Patra
- Abstract
Loading... -
+
P1.02-067 - FGF1 and IGF1 Co-Stimulation Promoted the Amplification and Cancer Stemness of Lung Cancer Cells under 3D Culture Condition
09:30 - 09:30 | Presenter: Rui Zhang
- Abstract
Loading... -
+
P1.02-068 - Effects of Pirfenidone Targeting EMT and Tumor-Stroma Interaction as Novel Treatment for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Ayako Fujiwara
- Abstract
Loading... -
+
P1.02-069 - Pemetrexed-Resistant Non-Small Cell Lung Cancer Cell Lines Have Novel Drug-Resistant Mechanisms
09:30 - 09:30 | Presenter: Ryosuke Tanino
- Abstract
Loading... -
+
P1.02-070 - Identification of Lung Cancer Specific Differentially Methylated Regions Using Genome-Wide DNA Methylation Study
09:30 - 09:30 | Presenter: Yoonki Hong
- Abstract
Loading... -
+
P1.02-071 - SFN Stabilizes Oncoproteins through Binding with SKP1 to Block SCFFBW7 Ubiquiting Ligase
09:30 - 09:30 | Presenter: Jeongmin Hong
- Abstract
Loading... -
+
P1.02-071a - Targeting Human Single Stranded DNA Binding Protein (hSSB) 1, a Novel Prognostic Factor, in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kenneth Obyrne
- Abstract
Loading... -
+
P1.02-071b - SASH1 Is a Prognostic Indicator and Future Target in NSCLC
09:30 - 09:30 | Author(s): J. Burgess
- Abstract
Loading...
first
prev
